Depression can feel overwhelming, especially when standard medications do not help. At Northern Virginia Psychiatric Group, we offer Spravato in Fairfax, VA, for adults with treatment-resistant depression. This FDA-approved treatment provides another option when traditional antidepressants fall short.
Our team provides Spravato treatment in Fairfax, VA, in a calm, supportive clinical environment. Care stays focused on safety, comfort, and long-term progress.
Spravato is a prescription nasal spray that contains esketamine and is taken in conjunction with an oral antidepressant. The FDA approved it for adults with treatment-resistant depression. Unlike standard antidepressants, Spravato targets the brain’s glutamate system, which plays a role in mood regulation.
Spravato is administered only in a medically supervised healthcare setting that holds special certification. Patients do not take Spravato home, and each treatment takes place under direct clinical oversight.
Spravato may help adults who have tried two or more antidepressants without adequate improvement. Many people seeking depression treatment in Fairfax, VA, explore Spravato after years of ongoing symptoms.
Before starting care, our psychiatrists complete a detailed evaluation. We review your mental health history, current medications, and treatment goals. This process helps ensure Spravato fits your needs, safely and effectively.
Northern Virginia Psychiatric Group provides Spravato in Fairfax, VA at our REMS-certified clinic. Board-certified psychiatrists oversee every treatment session in our office.
Patients self-administer the nasal spray under medical supervision, resting comfortably afterwards while being monitored for at least two hours.
Most patients begin with two sessions per week. Over time, visit frequency often decreases based on each patient’s response.
Missing a Spravato session does not always mean you need to start over. If you miss an appointment and your depressive symptoms remain stable, you can usually continue with your current dosing schedule.
However, if symptoms worsen after missed sessions, your psychiatrist may adjust your treatment plan. In some cases, this may mean returning to a more frequent dosing schedule for a period of time. For example, patients in weekly maintenance treatment may temporarily return to twice-weekly sessions.
At Northern Virginia Psychiatric Group, your care team monitors symptoms closely and makes adjustments based on clinical judgment. The goal is to maintain progress while keeping treatment safe and effective.
Many insurance plans, including Medicare, cover Spravato. Coverage varies by plan. Our team assists with benefit verification and explains costs clearly before treatment begins.
For more in-depth clinical information about Spravato, patients may review educational resources provided by the manufacturer at https://www.spravatohcp.com/resources/. These materials explain how Spravato works, safety guidelines, and treatment expectations.
If you have questions about whether Spravato is right for you, we encourage you to contact our office directly. Our team is happy to provide additional information and discuss next steps.
If you’re ready to see if Spravato in Fairfax, VA, is right for you, Northern Virginia Psychiatric Group is here to help.
Since 1978, Northern Virginia Psychiatric Group has been helping individuals and families throughout Fairfax and beyond find clarity, balance, and lasting emotional wellness. Our board-certified psychiatrists, therapists, and counselors provide compassionate, evidence-based care through both in-person and telemedicine sessions, ensuring you get the support you need in a way that works for you.
As a trusted psychiatry and behavioral health clinic serving Northern Virginia for over four decades, we proudly accept most major insurance providers. Visit our website or call 703-698-5220 today to schedule your confidential consultation and begin your path toward better mental health.
Yes. Spravato is FDA-approved and delivered as a nasal spray in a certified medical office. Ketamine infusions differ in form, regulation, and oversight.
No. Because Spravato can cause temporary side effects, you must arrange transportation home after each appointment.
If symptoms remain stable, you can usually continue your current dosing schedule. If symptoms worsen, your psychiatrist may recommend temporarily increasing visit frequency.
No. Federal guidelines do not allow samples of Spravato. All doses must be administered in a certified medical setting under supervision.